Business Wire

HiST Pharma Announces U.S. FDA Approval to Initiate Phase III Clinical Study With TC Cream – World’s First Botanical Small-Molecule Drug That Treats Psoriasis Vulgaris

GUANGZHOU, China--(BUSINESS WIRE)--HiST Pharma through its wholly-owned Psoriasis Research Institute of Guangzhou (PRIG) announces today that the U.S. Food and Drug Administration (FDA) has approved ...
C&EN

HIST celebrates centennial with special issue

The American Chemical Society Division of the History of Chemistry (HIST) turns 100 years old in 2022. HIST publishes a peer-reviewed journal on the history of chemistry, the Bulletin for the History ...